PMS-Ranitidine 150mg(2021-02-04)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
PMS-Ranitidine 150mg
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 623633, 624871, 626714, 626718 | PMS-Ranitidine 150mg | - Recalling Firm
- Pharmascience Inc.
- 6111 Royalmount Avenue, Office 100
- Montréal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 6111 Royalmount Avenue, Office 100
- Montréal
- H4P 2T4
- Quebec
- CANADA
| DIN 02242453 | Tablet | Ranitidine hydrochloride 150mg |
Presence of N-nitrosodimethylamine (NDMA) close to the acceptable concentration limit in affected lots.